CAMPANI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 720
NA - Nord America 696
AS - Asia 330
OC - Oceania 2
AF - Africa 1
Totale 1.749
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 690
IT - Italia 263
IE - Irlanda 143
HK - Hong Kong 138
RU - Federazione Russa 108
CN - Cina 93
SE - Svezia 80
PL - Polonia 53
JO - Giordania 35
SG - Singapore 35
FR - Francia 21
GB - Regno Unito 20
IN - India 12
RO - Romania 9
CA - Canada 6
DE - Germania 6
FI - Finlandia 6
KR - Corea 5
NL - Olanda 4
UA - Ucraina 4
VN - Vietnam 4
AU - Australia 2
BD - Bangladesh 2
CH - Svizzera 2
JP - Giappone 2
NP - Nepal 2
ID - Indonesia 1
LT - Lituania 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 1.749
Salva come PNG Salva come JPEG
Città #
Dublin 143
Hong Kong 98
Ashburn 93
Chandler 71
Fairfield 69
Florence 56
Warsaw 52
Lawrence 41
Altamura 40
Moscow 35
Shanghai 34
Houston 32
Cambridge 28
Beijing 26
Kent 24
Singapore 24
Woodbridge 24
Arezzo 22
Princeton 22
Wilmington 22
Buffalo 21
Seattle 19
Boston 18
Milan 18
Bologna 14
New York 14
Rome 14
West Jordan 14
Los Angeles 11
Paris 10
San Diego 10
Ann Arbor 9
London 9
Timisoara 9
Medford 7
Pune 5
Washington 5
Dong Ket 4
Hangzhou 4
Lappeenranta 4
Modena 4
Scandicci 4
Seoul 4
Toronto 4
Cagliari 3
Fontebuona 3
Menlo Park 3
Mumbai 3
Palermo 3
Perugia 3
Prato 3
Villaricca 3
Acerra 2
Acton 2
Albino 2
Aosta 2
Bari 2
Bern 2
Castelli Calepio 2
Central 2
Cerro al Volturno 2
Chennai 2
Chiswick 2
Dhaka 2
Falls Church 2
Genoa 2
Helsinki 2
Hillsboro 2
Kathmandu 2
Lodi 2
Lucca 2
Montepulciano 2
Osimo 2
Ottawa 2
Perth 2
Prescot 2
Redwood City 2
Rennes 2
Romainville 2
Saint-Fons 2
San Antonio 2
Silea 2
Southwark 2
Spoleto 2
Taranto 2
Tokyo 2
Treviso 2
Turin 2
Venice 2
Wuhan 2
Amsterdam 1
Andover 1
Azzano San Paolo 1
Berlin 1
Boardman 1
Bovisio-Masciago 1
Bremen 1
Brentford 1
Brindisi 1
Campagnola Emilia 1
Totale 1.301
Salva come PNG Salva come JPEG
Nome #
A large rheumatoid nodule mimicking hepatic malignancy 117
Long-term efficacy and safety of vedolizumab in patients with inflammatory bowel diseases: A real-life experience from a tertiary referral center 83
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 83
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives 82
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 79
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma 65
CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib 58
Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner 53
Time-varying mHAP III is the most accurate predictor of survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 49
Dynamics of endothelial progenitor cells in patients with advanced hepatocellular carcinoma 43
Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes 41
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 40
Circulating biomarkers of response to systemic treatments in advanced hepatocellular 39
Prevalence of nutritional risk and malnutrition during and after hospitalization for COVID-19 infection: Preliminary results of a single-centre experience 39
Biological therapies in patients with liver disease: are they really lifesavers? 38
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 37
Lenvatinib: established and promising drug for the treatment of advanced hepatocellular carcinoma 37
Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis 36
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma 36
Pattern of macrovascular invasion in hepatocellular carcinoma 36
The changing scenario of hepatocellular carcinoma in Italy: an update 36
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 35
Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey 34
Practical insights into chronic management of hepatic Wilson's disease 33
Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives 33
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 27
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 26
Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice 26
Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients 26
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study 24
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 24
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma 24
Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liver 24
An atypical case of palmo-plantar erythrodysesthesia related to cabozantinib 23
Metabolic disorders across hepatocellular carcinoma in Italy 23
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 22
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib 21
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs 20
Main factors influencing long-term outcomes of liver transplantation in 2022 19
Fragility index of positive phase II and III randomized clinical trials of treatments for hepatocellular carcinoma (2002-2022) 18
Needs evaluation questionnaire for liver disease: a novel assessment of unmet needs in patients with chronic liver disease 17
Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA 17
Systemic treatment of hepatocellular carcinoma: the times they are a-changin' 16
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients 16
Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab 16
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted Comparison 15
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 15
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib 13
Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab 12
Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab-bevacizumab 12
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study 11
No correlation between MASLD and poor outcome of Atezolizumab‐Bevacizumab therapy in patients with advanced HCC 11
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC 10
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 10
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care 9
Probiotics and the gut-liver axis 6
The upward trajectory of the UEG journal: Next Generation Trainee Editors 5
Quick and easy assessment of sarcopenia in cirrhosis: Can ultrasound be the solution? 5
Elusive Hepatic Nodules 4
Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 3
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in Lenvatinib 2
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 2
null 2
Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab 1
Totale 1.839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202064 0 1 0 4 5 4 7 10 8 12 10 3
2020/2021162 6 14 6 11 4 11 28 28 19 14 12 9
2021/2022194 15 1 7 2 2 13 0 10 31 34 32 47
2022/2023586 36 111 31 8 27 109 83 43 70 31 28 9
2023/2024669 23 39 56 18 35 71 42 198 26 71 58 32
2024/2025149 98 51 0 0 0 0 0 0 0 0 0 0
Totale 1.839